China SXT PharmaceuticalsSXTC 
$0.65-5.51%24h
-5.51%24h
Global rank
Market cap$368.73K
Change 7d13.19%
YTD Performance-75.02%
SP500 benchmarkUnderperform
P/E0
P/S0.19
Revenue$1.97M
Earnings-$5.93M
Dividend yield-
Main Sector
Healthcare
Category
China SXT Pharmaceuticals (SXTC) Total Liabilities
SXTC Total Liabilities in 2022: $14.86M
According to China SXT Pharmaceuticals latest financial reports the total liabilities of SXTC is $14.86M, an decrease of -13.19% to 2022. At the end of 2022 company had $17.12M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that China SXT Pharmaceuticals is responsible for during its operational activities.
China SXT Pharmaceuticals (SXTC) Total Liabilities History from 2023 to 2022
-
Value:-
SXTC Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $14.86M | -13.19% |
| 2022 | $17.12M | -7.88% |
| 2021 | $18.59M | 51.10% |
| 2020 | $12.30M | 437.43% |
| 2019 | $2.29M | - |
View the Top Total Liabilies Stocks
